TrialJournal of neuromuscular diseases2022

A Combined Prospective and Retrospective Comparison of Long-Term Functional Outcomes Suggests Delayed Loss of Ambulation and Pulmonary Decline with Long-Term Eteplirsen Treatment.

Olga Mitelman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.